Picterus

What Picterus does

Picterus AS is a Norwegian medical technology company headquartered in Trondheim that develops Picterus Jaundice Pro, a CE-marked Class IIa smartphone-based medical device for non-invasive neonatal jaundice screening. The system combines a smartphone application with a reusable Picterus Calibration Card placed on the newborn's chest; the app automatically captures six images per scan and uses proprietary computer vision and machine learning algorithms — trained on a database of 9,000+ verified scans across diverse skin tones — to estimate bilirubin levels within seconds, displaying results on AAP and NICE guideline nomograms corrected for gestational age. Data is processed and stored on EU-based cloud servers under GDPR-compliant, ISO 13485-certified, EU MDR 2017/745-regulated processes.

The company serves four overlapping customer segments: healthcare professionals (neonatologists, NICU physicians, pediatricians, midwives) for clinical and home-visit screening; hospitals and outpatient clinics via the Jaundice@Home subscription platform for multi-patient remote monitoring; parents for home-based screening under professional oversight; and NGOs/nonprofits in low-resource settings through the 2025-established Picterus Newborn Health subsidiary. Revenue is generated through three mechanisms: one-time purchases of calibration cards (€3-8 per card depending on volume), usage-based scan credits (€5.32-8.00 per scan, non-expiring), and custom-priced Jaundice@Home subscriptions for organizational deployments, with products distributed via a direct web shop, 12+ regional distributors across Europe and Asia, and an Amsterdam-based warehouse.

The business combines a product-led growth motion (free app download, in-app purchase of scans) with a channel-led motion through distributors and a community-led motion through nonprofit field programs in Nigeria, Zambia, and Tanzania. To date, 10,000+ newborns have been screened and 500+ healthcare professionals use the product across 15+ countries, with clinical validation conducted in 5,000+ newborns and additional peer-reviewed publications expected through 2026 in collaboration with institutions including Aga Khan University and Intermountain Health/University of Utah.

Name

Picterus

Legal name

Picterus AS

Website

https://picterus.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Picterus is a Norwegian MedTech company that sells Picterus Jaundice Pro, a CE-marked smartphone app paired with a calibration card for non-invasive neonatal jaundice screening, serving healthcare professionals, hospitals, parents, and NGO health programs across 15+ countries.

Ownership category

akta.pro rank

Product category

Neonatal Jaundice Screening Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Maternal, Neonatal & Pediatric Remote Monitoring (HLACAPAG)

Keywords

• Neonatal jaundice screening
• Smartphone medical devices
• Bilirubin estimation software
• Remote patient monitoring
• Digital health diagnostics

Headquarters

HQ city

Trondheim

HQ country

Norway

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Picterus Calibration Cards: Reusable calibration cards sold in packs of 1, 5, 20, or 50 units. Each card can be used multiple times on the same newborn. The card holder (sold separately for €5) enables the same card to be used on multiple babies with proper hygiene.
2. Picterus Scans: Consumable scan credits purchased in bundles of 3, 10, or 50. Each successful scan deducts one credit from the balance. Scans do not expire and are only consumed when a valid bilirubin result is displayed. Pricing is tiered by volume: €8/scan (3-pack), €6.6/scan (10-pack), €5.3/scan (50-pack).
3. Jaundice@Home Subscription: Professional subscription package for hospitals, outpatient clinics, and organizations that monitor multiple newborns. Includes Jaundice@Home platform access, organization account for scan distribution, calibration cards, scans, and accessories. Tailored to organizational needs with direct support from Picterus.
4. Bundle Packages: Pre-configured product bundles combining calibration cards, scans, and accessories at discounted rates compared to individual purchase. Bundle 1: €24 (1 card + 3 scans, value €32). Bundle 2: €69 (2 cards + 9 scans + card holder, value €93). Bundle 3: €163 (5 cards + 30 scans + card holder, value €218).

Pricing tiers

Go-to-market motion2 records

Distribution channels15 records

Marketing channels11 records

Core offering

Picterus sells the Picterus Jaundice Pro smartphone application, a CE-marked Class IIa medical device that uses computer vision and machine learning to estimate newborn bilirubin levels from images captured with a proprietary Picterus Calibration Card. Revenue is generated through sales of reusable calibration cards, consumable scan credits, the Jaundice@Home remote monitoring subscription for healthcare professionals, and bundle packages, with a free app download driving product-led adoption.

Product overview

Picterus offers a unified smartphone-based medical device ecosystem for neonatal jaundice screening. The core offering consists of the Picterus Jaundice Pro app (a CE-marked Class IIa medical device) used in combination with the Picterus Calibration Card and Picterus Scans (credits for each successful measurement). The system analyzes smartphone camera images of the newborn's chest with the calibration card to estimate bilirubin levels non-invasively. The Jaundice@Home platform extends capabilities with remote monitoring for healthcare professionals overseeing parent-performed scans at home. Additional products include the Picterus Card Holder accessory (enabling hygienic reuse across multiple babies), Picterus Education (free e-learning platform), and the upcoming Phototherapy Patch. The subsidiary Picterus Newborn Health focuses on nonprofit outreach in low-resource settings.

Differentiator

Problem solved

Functional benefit

Brands

• Picterus Jaundice Pro: Smartphone-based neonatal jaundice screening medical app used to screen newborns for jaundice, combining a smartphone app and Picterus Calibration Card for fast, accurate, and non-invasive bilirubin screening.
• Jaundice@Home

Quantifiable outcome

• 100% detection rate for newborns in need of phototherapy
• +5 more outcomes

Named customers11 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Aishatu Dammu Memorial HospitalcoreStrategic or Co-development Partner · 1 February 2026Partner for neonatal jaundice screening pilot feasibility project in Rigachikun, Nigeria (February-May 2026). Healthcare workers receive specialized training on neonatal jaundice and are equipped with Picterus Jaundice Pro to test integration into routine newborn care. The project also includes community awareness raising and donation of a phototherapy unit.
• Kapiri District HospitalcoreStrategic or Co-development Partner · 30 October 2025Partner in the Bright Starts quality improvement project for neonatal jaundice screening in Kapiri, Zambia. The project introduced Picterus Jaundice Pro to strengthen early detection and management of neonatal jaundice, with screening activities extending to Kapiri Urban Clinic and referral pathways.
• Tanzania Better HealthcoreStrategic or Co-development Partner · 11 March 2025Local partner in Tanzania conducting community health outreach to strengthen early detection and community awareness of neonatal jaundice in the Monduli region. Healthcare workers screened newborns across three locations using Picterus Jaundice Pro during pre-planned community health outreach activities.
• The Wellbeing Foundation AfricacoreStrategic or Co-development Partner · 1 January 2024Picterus Newborn Health collaborates with The Wellbeing Foundation Africa under Project Oscar – Light for Life, a neonatal jaundice screening, treatment, and kernicterus prevention programme in Nigeria. Picterus Jaundice Pro is integrated into maternal, neonatal, and community health workflows. The project supports frontline health workers with targeted training, clinical decision-making tools, and non-invasive screening for early identification of at-risk newborns. Funded by Reckitt and implemented in collaboration with government stakeholders.
• DayOneHealthminorOthersDonated a phototherapy unit to Kapiri Urban Clinic in Zambia to support on-site treatment for newborns identified as needing care through the Bright Starts project.
• Academic and Clinical Research PartnerscoreStrategic or Co-development PartnerPicterus has collaborated with clinical and academic partners worldwide to develop and validate the technology. Multiple peer-reviewed publications have been generated through collaborations with institutions including Aga Khan University (Pakistan), Intermountain Health/University of Utah (USA), and various hospitals in Mexico, Nigeria, Tanzania, and other countries. Manuscripts have been submitted for peer review expected to be published in 2026.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• BabyScripts: BabyScripts is a digital maternal health platform that supports remote monitoring of pregnancies and postpartum care. It is comparable to Picterus in its software-first, remote-monitoring approach to maternal/neonatal health, although focused on a different clinical workflow.
• Novioscan: Novioscan develops wearable neonatal monitoring technology, overlapping with Picterus on the digital neonatal monitoring thesis. While its current product focus is different, it represents a comparable European emerging player pursuing smartphone-/sensor-based newborn health monitoring.
• Bistos: Bistos manufactures neonatal care equipment including phototherapy devices and bilirubin monitors. While broader than Picterus, it competes for the same nursery budgets and represents an emerging alternative in mid-tier markets.

Direct peers

• Masimo: Masimo manufactures transcutaneous bilirubinometers (e.g., Manta, Rad-G) used in hospitals for non-invasive neonatal jaundice screening. It is the dominant incumbent in the same clinical category as Picterus, with established FDA-cleared devices and global hospital procurement relationships.
• Draeger: Draeger produces the JM-103 and JM-105 jaundice meters, the most widely deployed transcutaneous bilirubinometers in maternity wards globally. As an established medical device incumbent with full neonatal care portfolios, Draeger competes directly for the same hospital screening budget that Picterus targets.
• Natus Medical: Natus Medical (now part of ArchiMed) historically manufactured bilirubin meters and a broad range of neonatal care devices. It is a relevant peer because it sells directly into the same NICU and nursery procurement channels that Picterus needs to win.
• Konica Minolta Healthcare: Konica Minolta acquired the BiliChek transcutaneous bilirubinometer line, a direct competitor to Picterus Jaundice Pro. Its installed base in hospitals and established distribution make it one of the closest analog competitors in the non-invasive neonatal bilirubin measurement category.
• Mennen Medical: Mennen Medical supplies bilirubin analyzers and other point-of-care neonatal diagnostic devices. As a smaller, more focused competitor in transcutaneous bilirubinometry, it is comparable to Picterus in scale and target customer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xwa.me/4790719195
• YouTubeyoutube.com/@Picterus
• Facebookfacebook.com/picterus
• LinkedInlinkedin.com/company/picterus-as
• Instagraminstagram.com/picterus_jaundice

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds9 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Picterus